Evidence map›Paper›PMID 35469230›Full record

Trial reportJournal of healthcare engineering2022

Stereotactic Aspiration Acts as an Effective Treatment for Malignant Middle Cerebral Artery Infarction.

Zhiyu Wang, Maogang Chen, Chong Wang, Jinbiao Luo, Shujie Sun, Xiangui Lu

RetractedAbstract readRandomized Controlled TrialRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Zhiyu WangDepartment of Neurosurgery, Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Affiliated to Fudan University, Shanghai Clinical Center CAS, Shanghai 200031, China.
Maogang ChenDepartment of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 211299, China.
Chong WangDepartment of Neurosurgery, Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Affiliated to Fudan University, Shanghai Clinical Center CAS, Shanghai 200031, China.ORCID 0000-0002-7632-228X
Jinbiao LuoDepartment of Neurosurgery, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China.
Shujie SunDepartment of Neurosurgery, Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Affiliated to Fudan University, Shanghai Clinical Center CAS, Shanghai 200031, China.ORCID 0000-0002-1983-0851
Xiangui LuDepartment of Neurosurgery, Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Affiliated to Fudan University, Shanghai Clinical Center CAS, Shanghai 200031, China.ORCID 0000-0002-6353-745X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study seeks to explore the efficacy and prognosis of stereotactic aspiration for malignant middle cerebral artery infarction (mMCAI). Methods: A total of 50 mMCAI patients who were diagnosed and treated in our hospital from January 2018 to June 2020 were collected and then randomly divided into control group (decompressive craniectomy, Results: One month after treatment, the GCS scores and Barthel Index score increased in both the control and study groups and were significantly higher in the study group. The follow-up results at 1 and 6 months after treatment showed that in comparison with the control group, stereotactic aspiration led to a higher survival rate and lower mortality rate; the latter had superior NIHSS score and mRS score and better prognosis. Conclusion: In comparison with decompressive craniectomy, stereotactic aspiration shows outstanding clinical efficacy and more advantages in the treatment of mMCAI. Therefore, stereotactic aspiration is more worthy of clinical application.

Indexed as

CraniotomyInfarction, Middle Cerebral ArteryGlasgow Coma ScaleHumansPrognosisRetrospective StudiesStereotaxic TechniquesTreatment OutcomeUnited States

Identifiers

PMID35469230
PMCPMC9034930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.